MARTEC USA LLC
GenericsMARTEC USA LLC is a generic drug manufacturer focused on Cardiovascular.
MARTEC USA LLC's Key Drugs
MARTEC USA LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MARTEC USA LLC's Recent FDA Approvals
New NDA/BLA approvals for MARTEC USA LLC over the last two years — novel drugs only, excluding generics and label supplements.
MARTEC USA LLC's Therapeutic Areas
MARTEC USA LLC's approved drugs and pipeline span 1 therapeutic area, led by Cardiovascular, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MARTEC USA LLC's Top Competitors
MARTEC USA LLC's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MARTEC USA LLC Pipeline Snapshot
Active clinical trials for MARTEC USA LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2004-03-23
- Latest
- 2004-03-23
- Applications
- 4